Literature DB >> 20624799

Duration of illness in infants with bronchiolitis evaluated in the emergency department.

Frank D Petruzella1, Marc H Gorelick.   

Abstract

OBJECTIVES: To describe the duration of illness in infants with first-time bronchiolitis who present to an emergency department (ED) and assess the burden of the illness on caregivers and families.
METHODS: This was a prospective cohort study of infants younger than 12 months who presented to a tertiary care children's hospital ED with a first episode of bronchiolitis. Subjects were excluded if they had a history of bronchodilator use or immunocompromise. Demographic and clinical data were collected in the ED. Outcomes data were collected by weekly telephone interviews for 4 weeks or until the subject was free of cough for 24 hours.
RESULTS: Ninety-five infants were enrolled from November 2007 to March 2008. Median duration of symptoms was 15 days; 25% of the infants remained symptomatic after 21 days. Subjects with a history of eczema trended toward a longer median duration of symptoms when compared with those who did not (18 days [interquartile range (IQR): 15.5-24] and 15 days [IQR: 11-19], respectively; P = .055). Duration of symptoms did not significantly vary with regards to respiratory syncytial virus status or secondhand smoke exposure. Subjects missed a median of 2.5 days (IQR: 0.5-5.5) of day care, and caregivers missed a median of 2 days (IQR: 1-4) of work. Of these infants, 37.1% (95% confidence interval: 24.3-44.1) had a subsequent unscheduled medical visit.
CONCLUSIONS: Infants seen in the ED for bronchiolitis have a prolonged disease course, with substantial burden to the family. Symptom duration may be influenced by a propensity toward atopy. Clinicians may use this information for counseling families.

Entities:  

Mesh:

Year:  2010        PMID: 20624799     DOI: 10.1542/peds.2009-2189

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

1.  Secondhand smoke exposure, illness severity, and resource utilization in pediatric emergency department patients with respiratory illnesses.

Authors:  Ashley L Merianos; Cinnamon A Dixon; E Melinda Mahabee-Gittens
Journal:  J Asthma       Date:  2016-12-08       Impact factor: 2.515

2.  Relationship of secondhand smoke and infant lower respiratory tract infection severity by familial atopy status.

Authors:  Meghan Lemke; Tina V Hartert; Tebeb Gebretsadik; Kecia N Carroll
Journal:  Ann Allergy Asthma Immunol       Date:  2013-06       Impact factor: 6.347

3.  Frequency, duration and predictors of bronchiolitis episodes of care among infants ≥32 weeks gestation in a large integrated healthcare system: a retrospective cohort study.

Authors:  Valerie J Flaherman; Arona I Ragins; Sherian Xu Li; Patricia Kipnis; Anthony Masaquel; Gabriel J Escobar
Journal:  BMC Health Serv Res       Date:  2012-06-08       Impact factor: 2.655

Review 4.  Duration of symptoms of respiratory tract infections in children: systematic review.

Authors:  Matthew Thompson; Talley A Vodicka; Peter S Blair; David I Buckley; Carl Heneghan; Alastair D Hay
Journal:  BMJ       Date:  2013-12-11

5.  Hospital course and discharge criteria for children hospitalized with bronchiolitis.

Authors:  Jonathan M Mansbach; Sunday Clark; Pedro A Piedra; Charles G Macias; Alan R Schroeder; Brian M Pate; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo
Journal:  J Hosp Med       Date:  2015-01-28       Impact factor: 2.960

6.  Intermittent versus continuous oxygen saturation monitoring for infants hospitalised with bronchiolitis: study protocol for a pragmatic randomised controlled trial.

Authors:  Sanjay Mahant; Gita Wahi; Lucy Giglia; Catherine Pound; Ronik Kanani; Ann Bayliss; Madan Roy; Mahmoud Sakran; Natascha Kozlowski; Karen Breen-Reid; Mollie Lavigne; Laila Premji; Myla E Moretti; Andrew R Willan; Suzanne Schuh; Patricia C Parkin
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

7.  The heterogeneity of asthma phenotypes in children and young adults.

Authors:  Bill Hesselmar; Anna-Carin Enelund; Bo Eriksson; Leonid Padyukov; Lars Å Hanson; Nils Aberg
Journal:  J Allergy (Cairo)       Date:  2012-04-11

8.  Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making.

Authors:  Asad I Mian; Mayank Aranke; Nathan S Bryan
Journal:  Open Biochem J       Date:  2013-03-08

9.  Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.

Authors:  Gabrielle B McCallum; Peter S Morris; Keith Grimwood; Carolyn Maclennan; Andrew V White; Mark D Chatfield; Theo P Sloots; Ian M Mackay; Heidi Smith-Vaughan; Clare C McKay; Lesley A Versteegh; Nerida Jacobsen; Charmaine Mobberley; Catherine A Byrnes; Anne B Chang
Journal:  Front Pediatr       Date:  2015-04-21       Impact factor: 3.418

10.  Risk factors for adverse outcomes of Indigenous infants hospitalized with bronchiolitis.

Authors:  Gabrielle B McCallum; Mark D Chatfield; Peter S Morris; Anne B Chang
Journal:  Pediatr Pulmonol       Date:  2015-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.